徐工集团财务有限公司

冰川科技

我司先后成立了北京冰川制冷空调设备有限公司、固安冰川制冷设备有限公司和任丘市冰川科技有限公司。生产基地位于廊坊市固安县开发区南区和沧州市任丘经济开发区，是一家集设计、加工为一体的高新技术企业，专业生产各类空调换热器，主要产品包括翅片式换热器、管束套管式换热器、同轴套管式换热器、高效罐式换热器、高效新型管壳式换热器及风机盘管机组。

产品广泛应用于中央空调、铁路列车空调、汽车空调、家用空调、医疗空调、机房基站空调、冷冻设备、新风组合空调、热泵机组等领域，已服务于长客标动、冬奥会场馆、旧金山地铁、欧洲之星、美国基站、印度基站、伦敦地铁、英国基站以及各地煤改电等项目。

西安欢派信息咨询有限公司

**主要服务领域：**

- **信息咨询服务**（非许可类）
- **信息技术咨询服务**
- **企业管理咨询**
- **办公设备耗材销售**
- **酒店管理**
- **装卸搬运**
- **信息系统集成服务**
- **教育咨询服务**（不含特定教育培训活动）
- **企业管理**

**自主经营范围：** 通过营业执照合法独立开展上述所有业务。

**许可经营项目：**

- **建筑劳务分包**
- **建设工程施工**
- **职业中介活动**

**需审批项目：** 开展上述许可项目前，必须获得相关部门的批准，并依据审批结果进行经营活动。

泽宇智能

江苏泽宇智能电力股份有限公司成立于2011年11月18日，注册资本23917万元。公司旗下拥有江苏泽宇电力设计有限公司、江苏泽宇电力工程有限公司、江苏泽宇智能新能源有限公司、泽宇智能（福建）电力有限责任公司、江苏泽宇新森智能设备有限公司等多家子公司。公司专注于提供电力信息系统整体解决方案，涵盖电力咨询设计、系统集成业务、工程施工及运维等一站式智能电网综合服务。2021年12月，公司成立了全资子公司江苏泽宇智能新能源有限公司，主要负责电站开发、电站服务、能源服务等业务，致力于成为行业内领先的智慧能源综合服务提供商。公司被江苏省民营科技企业协会授予“江苏省民营科技企业”称号，并获得南通市崇川区人民政府颁发的“十强工业企业”和“十佳服务业企业”荣誉。公司技术研究院被评为南通市科技局的“企业工程技术研究中心”，并与华北电力大学共建研究生工作站，是国内首批通过中国电力科学研究院网络安全监测装置检测的十家合格供应商之一。公司持有信息系统服务交付能力等级证书（一级）、电力行业（送电、变电、新能源）工程设计乙级资质、通信工程施工总承包叁级、电力工程施工总承包叁级、电子与智能化工程专业承包贰级等资质。凭借多年在电力信息化领域的技术和经验积累，公司能够为客户提供全方位的智能电网综合服务。公司服务和解决方案广泛应用于电力系统的发电、输电、变电、配电、用电和调度等多个环节。近年来，公司参与并承建了包括“北京至上海光传输设备改造项目”、“国家电网公司大容量骨干光传输网新疆延伸覆盖工程甘肃地区施工”、“青海-河南±800千伏特高压直流输电光纤通信工程包8甘肃地区通信设备安装施工”、“国网江苏省电力有限公司调度管理信息大区数据网二平面系统建设”在内的多个国家级重点电网项目。

武汉梦川信息咨询有限公司

武汉梦川信息咨询有限公司，公司规模少于50人，公司类型为民营公司，所属行业为金融/投资/证券。

中美冠科生物技术(太仓)有限公司

Crown Bioscience (Taicang) Biotechnology Co., Ltd.
Established at the end of 2008, Crown Bioscience Taicang branch is located within the Science and Technology Park in Taicang City, Jiangsu Province. With a registered capital of $10 million and a total investment of $20 million, the company has approximately 300 employees, 89.9% of whom hold bachelor's degrees or higher. The core R&D and management team members have an average of more than 15 years of experience in international pharmaceutical and biopharmaceutical industries. Crown Bioscience Taicang branch has 4,500 square meters of AAALAC-certified animal research facilities, 11,000 square meters of modern laboratories, and 3,600 square meters of office space. It has established a comprehensive one-stop R&D service platform from early target screening in drug discovery to clinical candidate drug development.

Address: Unit E304, North Block B Building, Star Lake Street 218, Suzhou Industrial Park, Jiangsu Province.

Transportation: Located north of Taicang Coach Station, at the intersection of Taiping Road and Beijing Road. It takes about 10-15 minutes to walk or 10 yuan by taxi.

Crown Bioscience (Beijing) Co., Ltd.
Founded in July 2006, Crown Bioscience Beijing branch is located in the Changping District of Beijing Zhongguancun Science Park. With a registered capital of $2.81 million and a total investment of $10 million, the company has around 160 employees, 85.1% of whom hold bachelor's degrees or higher. As a professional CRO (Contract Research Organization) service company, we are dedicated to providing high-quality, efficient, and cost-effective preclinical R&D services for new drug development clients. Crown Bioscience Beijing branch has a complete and independent modern biomedical research base of 4,000 square meters, including a 1,000-square-meter animal facility that meets international standards, capable of housing both small and large animals. In 2014, it was rated as a provincial anti-tumor drug R&D base, and in 2015, it was recognized as a technology-advanced service enterprise in Beijing.

Address: 4th Floor, Yilan Building, No. 28 Huojushu Street, Changping Torch Park, Changping District, Beijing.

Crown Bioscience (Suzhou) Co., Ltd.
Founded in October 2018, Crown Bioscience Suzhou branch is located in Unit E304, North Block B Building, Star Lake Street 218, Suzhou Industrial Park, Jiangsu Province.

Crown Bioscience (Zhongshan) Co., Ltd.
Established in May 2019, Crown Bioscience Zhongshan branch is located inside Lipusheng Science and Technology Park, Cuihuan New Area, Zhongshan City, Guangdong Province. It officially commenced operations in late October 2020.

We sincerely appreciate the attention and understanding of all applicants!